16 April 2020 | News
The company will help conduct prescribed diagnostic tests and issue a formal report for the same
Redcliffe Life Sciences, molecular diagnostics company, has partnered with the Birbal Sahni Institute of Palaeoscience (BSIP), Lucknow in a bid to contribute to the ongoing diagnostics and discoveries around COVID-19.
While BSIP, which is accredited by the Department of Science and Technology (DST) has been appointed as the sample analyzing center (SAC), Redcliffe will provide infectious diagnostic testing services for COVID-19.
The partnership is in line with Redcliffe’s efforts towards helping in the research around the recent health pandemic and discussions to offer support with some equipped institutions that have BSL2 facilities. The diagnostic company recently got approval for this unique PPP model from BSIP.
Speaking about this, Ashish Dubey, Co-Founder, Redcliffe Life Sciences, said, “We are happy to be associated with the Department of Science & Technology, Government of India affiliated Birbal Sahni Institute of Palaeoscience (BSIP) for a contribution towards the research around the novel coronavirus. With our combined capabilities, we hope to become a game-changer in the efforts towards tackling the pandemic and assist the governmental efforts in this direction. There are not many testing labs in Uttar Pradesh and given the need for testing in a large set of population, we are keeping ourselves ready with the infrastructure.”
Dr. Vandana Prasad, Director, BSIP and Dr. Niraj Rai, in-charge of ancient DNA lab at BSIP Lucknow said, “As part of the association, BSIP will provide up and running infrastructure BSL2 and above, as per the ICMR guidelines. The institution will also design the assays and protocols to test the presence and absence of COVID 19 using RT-PCR as per the ICMR guidelines. Redcliffe, on its part, will help conduct a prescribed diagnostic test within a set turn-around time (calculated from the sample receipt) and issue a formal test report using their manpower who are trained at handling infectious samples.”
The Redcliffe team along with Dr. Niraj Rai and his team at BSIP are working on a mass-screening assay to diagnose a large population using a mass array technology.
Redcliffe will also provide special pricing for tests generated by BSIP or follow the ICMR guidelines when testing for any other such government institutions. The company will provide sample collection kits (wherever necessary) apart from manpower, logistics, and the necessary reagents/kits to BSIP. It will further help in waste management and disposal of the biological material as per ICMR guidelines.